U.S. Poison Control Ivermectin Data Analyzed by TrialSite – Some Surprises

The U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and prominent physician and pharmacy societies have stepped up and intensified warnings about the use of ivermectin across mass media.  While a recent American Medical Association warning press release cites a huge rise in ivermectin prescriptions and a 3-Fold increase in calls to poison control centers associated with the misuse of the generic drug no context or data is offered. All of the prescriptions reported are associated with physician prescriptions to consenting patients for the over-the-counter use against ivermectin. An improper channel involves the procurement and inappropriate use of the animal version of the drug. Media messaging appears to often conflate these two distinct use cases. TrialSite recently reported that the American Medical Association (AMA), prominent pharmacy societies, and one of the makers of ivermectin, Merck declared war on the economical, generic drug that’s treated over 4 billion people in the tropics alone helping to manage diseases such as River Blindness. Mainstream media seemingly without any critical questioning merely parrots what the various gove...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee